Nuvation Bio Inc.
NUVB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811063
In the last 90 days, Nuvation Bio Inc. insiders filed 0 open-market purchases and 1 sale; 244 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; 3 superinvestors hold it, including Duquesne Family Office and Abrams Capital.
13F holders, Q1 2022
Institutional positions in Nuvation Bio Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +12 vs. Q4 2021
- Shares held
- 159.2M
- +3.81M (+2.5%) vs. Q4 2021
- Total value
- $837.0M
- −$482.6M (−36.6%) vs. Q4 2021
- New holders
- 19
- 37 more added
- Sold out
- 7
- 36 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 244 | $1.33B |
| Q1 2026 | 233 | $947.4M |
| Q4 2025 | 224 | $1.89B |
| Q3 2025 | 203 | $817.8M |
| Q2 2025 | 182 | $439.1M |
| Q1 2025 | 161 | $364.9M |
| Q4 2024 | 160 | $526.0M |
| Q3 2024 | 154 | $428.6M |
| Q2 2024 | 148 | $447.0M |
| Q1 2024 | 124 | $490.1M |
| Q4 2023 | 116 | $202.7M |
| Q3 2023 | 125 | $183.4M |
| Q2 2023 | 124 | $250.2M |
| Q1 2023 | 129 | $228.2M |
| Q4 2022 | 127 | $267.9M |
| Q3 2022 | 122 | $317.5M |
| Q2 2022 | 120 | $503.2M |
| Q1 2022 | 117 | $837.0M |
| Q4 2021 | 105 | $1.32B |
| Q3 2021 | 98 | $1.50B |
| Q2 2021 | 99 | $1.36B |
| Q1 2021 | 73 | $1.48B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Nuvation Bio Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,769,701 | $9.31M | 0.19% | −1,151,122−39.4% | Reduced |
| Geode Capital Management, LLC | 2,273,471 | $12.0M | 0.00% | +115,891+5.4% | Added |
| Aisling Capital Management LP | 2,541,009 | $13.4M | 7.21% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,900,000 | $15.3M | 0.08% | +1,470,000+102.8% | Added |
| State Street Corp | 2,996,847 | $15.8M | 0.00% | +262,811+9.6% | Added |
| Redmile Group, LLC | 3,471,709 | $18.3M | 0.57% | −199,300−5.4% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,577,233 | $18.8M | 0.42% | 00.0% | Unchanged |
| Abrams Capital Management, L.P.SuperinvestorAbrams Capital | 3,811,513 | $20.0M | 0.47% | 00.0% | Unchanged |
| Boxer Capital, LLC | 4,341,009 | $22.8M | 1.17% | 00.0% | Unchanged |
| Avidity Partners Management LP | 4,855,006 | $25.5M | 0.57% | −2,527,482−34.2% | Reduced |
| Citadel Advisors LLC | 5,985,223 | $31.5M | 0.04% | +480,952+8.7% | Added |
| Baupost Group LLCSuperinvestorBaupost Group | 10,443,494 | $54.9M | 0.59% | +1,820,473+21.1% | Added |
| BlackRock Inc. | 11,252,055 | $59.2M | 0.00% | +455,021+4.2% | Added |
| Vanguard Group Inc | 12,932,460 | $68.0M | 0.00% | +1,671,908+14.8% | Added |
| EcoR1 Capital, LLC | 13,896,543 | $73.1M | 2.29% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 22,957,340 | $120.8M | 24.71% | 00.0% | Unchanged |
| FMR LLC | 31,598,727 | $166.2M | 0.01% | −67,313−0.2% | Reduced |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −727,956−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −359,375−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −179,245−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −33,816−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −504−100.0% | Sold out |